UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
September 5, 2023 5:30 P.M.
Form:
S-4
CIK:
0001603207
Company Name:
Vascular Biogenics Ltd.
File Number:
333-271826